Holm et al. [39] reported a correlation between elevated serum FGF2 levels in the first three postnatal weeks and the risk of pre-threshold ROP, but Yu et al. [36] found no significant difference in serum FGF2 levels at birth between patients with ROP and non-ROP controls. Here, FGF2 is linked to retinopathy of prematurity.